Andreea M. Bujor, MD, PhD

Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

I am an Associate Professor of Medicine in the Section of Rheumatology at Boston University School of Medicine, specializing in scleroderma translational research and in the care of patients with scleroderma.

My research focuses on the interplay between myeloid cells and fibroblasts in scleroderma-associated cardiac fibrosis. Our project investigating the role of the transcription factor Fli1 in myeloid cells has received funding from the NIH, American Heart Association, and Rheumatology Research Foundation. Additionally, we are exploring a method called spatial frequency domain imaging as a non-invasive tool for assessing skin fibrosis in scleroderma patients, a project supported by the Scleroderma Clinical Trials Consortium and National Scleroderma Foundation.

Beyond research, I am deeply committed to mentoring and education. As the Associate Program Director for the Rheumatology Fellowship, I have mentored trainees at all levels, and received an Outstanding Mentor Award from UROP. I regularly lecture on scleroderma and rheumatology and lead board review sessions for fellows. In recognition of my contributions to clinical care and research, I was honored as one of Boston’s Top Doctors in 2024 and 2025.

Publications

  • Published 10/14/2026

    Vo H, Mehendale AM, Azzam M, Pilvar A, El Adili F, Patel R, Chamis B, Ramasubramanian A, Kissin B, York M, Trojanowski M, Jafarzadeh SR, Browning J, Bhawan J, Roblyer D, Bujor AM. Spatial frequency domain imaging for assessment of skin fibrosis in systemic sclerosis: a prospective cohort study. Lancet Rheumatol. 2026 Oct 14. PMID: 42874627.

    Read at: PubMed

  • Published 9/1/2026

    El Adili F, Moyo KM, Vo H, Kissin B, Yang J, Dinc MT, Browning J, Pimentel D, Fitzgibbons T, Slavin S, Qin F, Trojanowska M, Bujor AM. Down-Regulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis Via a Galectin-3/mTOR Dependent Pathway. Arthritis Rheumatol. 2026 Sep 01. PMID: 42681974.

    Read at: PubMed

  • Published 5/11/2026

    Lui JK, Patel R, Luong HL, Au M, El-Adili F, Chamis B, Trojanowski MA, LaValley MP, Gopal DM, Klings ES, Bujor AM. Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension. Arthritis Rheumatol. 2026 May 11. PMID: 42112843.

    Read at: PubMed

  • Published 4/20/2026

    Romich E, Ogdie A, Stephens Shields A, Merkel PA, Assassi S, Bernstein EJ, Bujor A, Castelino FV, Chung L, Evnin LB, Frech TM, Gordon JK, Griffith M, Hant FN, Harding ML, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina DJ, Luo Y, Makol A, Mayes MD, McMahan ZH, Molitor J, Moore DF, Paik J, Richardson C, Skaug B, Shah AA, Shah A, Steen V, VanBuren JM, Volkmann ER, Zahn C, Sandorfi N. Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis. Arthritis Care Res (Hoboken). 2026 Apr 20. PMID: 42007807.

    Read at: PubMed

  • Published 2/4/2026

    Lui JK, Cozzolino M, Winburn M, Trojanowski MA, LaValley MP, Bujor AM, Gopal DM, Klings ES. Risk stratifying systemic sclerosis-related pulmonary hypertension by left atrial strain. Rheumatology (Oxford). 2026 Feb 04; 65(2). PMID: 41615697.

    Read at: PubMed

View All 52 Publications:   View Full Profile in BUMC

Other Positions

  • Associate Program Director, Arthritis & Autoimmune Diseases Research Center
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University
  • Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
    Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Websites

Education

  • Iuliu Hațieganu University of Medicine and Pharmacy, MD
  • Iuliu Hațieganu University of Medicine and Pharmacy, PhD
  • Iuliu Hațieganu University of Medicine and Pharmacy, MS

View all profiles